Abstract:Rationale: Circular RNA (circRNA) therapeutics hold great promise as an iteration strategy in messenger RNA (mRNA) therapeutics due to their inherent stability and durable protein translation capability. Nevertheless, the efficiency of RNA circularization remains a significant constraint, particularly in establishing large-scale manufacturing processes for producing highly purified circRNAs. Hence, it is imperative to develop a universal and more efficient RNA circularization system when considering synthetic circRNAs as therapeutic agents with prospective clinical applications. Methods: We initially developed a chimeric RNA circularization system based on the original permuted intron-exon (PIE) and subsequently established a high-performance liquid chromatography (HPLC) method to obtain highly purified circRNAs. We then evaluated their translational ability and immunogenicity. The circRNAs expressing human papillomavirus (HPV) E7 peptide (43-62aa) and dimerized receptor binding domain (dRBD) from SARS-CoV-2 were encapsulated within lipid nanoparticles (LNPs) as vaccines, followed by an assessment of the in vivo efficacy through determination of antigen-specific T and B cell responses, respectively. Results: We have successfully developed a universal chimeric permuted intron-exon system (CPIE) through engineering of group I self-splicing introns derived from Anabaena pre-tRNALeu or T4 phage thymidylate (Td) synthase gene. Within CPIE, we have effectively enhanced RNA circularization efficiency. By utilizing size exclusion chromatography, circRNAs were effectively separated, which exhibit low immunogenicity and sustained potent protein expression property. In vivo data demonstrate that the constructed circRNA vaccines can elicit robust immune activation (B cell and/or T cell responses) against tumor or SARS-CoV-2 and its variants in mouse models. Conclusions: Overall, we provide an efficient and universal system to synthesize circRNA in vitro, which has extensive application prospect for circRNA therapeutics.

Study of circular RNA translation using reporter systems in living cells

CircPro: an Integrated Tool for the Identification of Circrnas with Protein-Coding Potential.

Systematic screen of RNA binding proteins that enhance circular RNA translation

Circular RNA: an emerging key player in RNA world.

Molecular mechanisms of circular RNA translation

Engineering circular RNA for enhanced protein production

A Simple and Efficient One-Step Synthesis System for Flexible Production of Circular RNA in E. coli

Engineering circular RNA regulators to specifically promote circular RNA production

Circular RNA translation, a path to hidden proteome

Expanding uncapped translation and emerging function of circular RNA in carcinomas and noncarcinomas

Translation and functional roles of circular RNAs in human cancer

TransCirc: an interactive database for translatable circular RNAs based on multi-omics evidence

Efficient circularization of protein-encoding RNAs via a novel cis -splicing system

circFL-seq reveals full-length circular RNAs with rolling circular reverse transcription and nanopore sequencing.

Analytical Methods and Platforms for circRNA Vector Engineering to Improve Circularization Efficiency

Developing an enhanced chimeric permuted intron-exon system for circular RNA therapeutics

Newly Discovered Circrnas Encoding Proteins: Recent Progress

Engineering circular RNA for molecular and metabolic reprogramming

Comprehensive profiling of circular RNAs with nanopore sequencing and CIRI-long

Circular RNA profiling provides insights into their subcellular distribution and molecular characteristics in HepG2 cells.

Screening for functional circular RNAs using the CRISPR–Cas13 system